Agrasen Meditech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 06-07-2024
- Paid Up Capital ₹ 0.10 M
as on 06-07-2024
- Company Age 4 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 577.66%
(FY 2022)
- Profit 73.42%
(FY 2022)
- Ebitda 92.39%
(FY 2022)
- Net Worth -38.72%
(FY 2022)
- Total Assets 74.06%
(FY 2022)
About Agrasen Meditech
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ghanshyam Gupta, Mohan Gupta, and Mohit Gupta serve as directors at the Company.
- CIN/LLPIN
U24236RJ2020PTC069870
- Company No.
069870
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Jul 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Agrasen Meditech Private Limited offer?
Agrasen Meditech Private Limited offers a wide range of products and services, including Physiotherapy & Rehab Aids, Rehabilitation Equipment, Bandages & Dressing Disposables, Medical Gauze, Cotton Crepe Bandages, Bandages, Gauze Roll Bandage.
Who are the key members and board of directors at Agrasen Meditech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ghanshyam Gupta  | Director | 25-Jul-2020 | Current |
| Mohan Gupta | Director | 25-Jul-2020 | Current |
| Mohit Gupta | Director | 25-Jul-2020 | Current |
Financial Performance of Agrasen Meditech.
Agrasen Meditech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 577.66% increase. The company also saw a substantial improvement in profitability, with a 73.42% increase in profit. The company's net worth observed a substantial decline by a decrease of 38.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Agrasen Meditech?
In 2022, Agrasen Meditech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Agrasen Meditech?
Agrasen Meditech has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Agrasen Meditech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Agrasen Meditech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
